of a frequency and type that are characteristic for the given strain (Griineberg, 1952) . It is clear that the differences between strains in the numbers and types of malformations they manifest are genetic in origin, but it is not clear why some animals within a litter are born defective while their genetically indistinguishable litter-mates are normal.
The congenital cleft lip that occurs in the highly inbred A/Jax mouse strain is a case in point. In litters observed just before term about 14 % of the embryos have a cleft lip, usually with an associated cleft palate. More or less tenuous associations have been observed between cleft lip frequency and maternal age (Reed, 1936; Davidson, i963) , litter size (Davidson) , and uterine position (Trasler, I960) , but these will not account for the fact that in a representative AIJax litter one or two animals have a cleft lip and the others are normal. One postulated explanation is that the increased homozygosity resulting from inbreeding makes the embryo developmentally unstable (Lerner, 1954) . If so, it should be easy to increase the frequency of cleft lip in the A/Jax strain by exposing the mother to various teratogenic agents during pregnancy, but experiments with a number of teratogens have not supported this hypothesis (D. G. Trasler, personal communication) . In the present paper an increase in the frequency of cleft lip in A/Jax embryos at term following maternal treatment with 6-aminonicotinamide is shown to result not from the production of cleft lip by the treatment but from the resistance of embryos with 'spontaneous' cleft lip to a dose of the teratogen that kills most of their normal litter-mates.
During a study of the teratogenic effects of the nicotinamide analogue 6-amino-nicotinamide (6AN) in the mouse (Pinsky and Fraser, I959, I960; Goldstein, Pinsky, and Fraser, i963) , the nature and frequency of defects in the offspring following treatment of the mother during pregnancy were found to depend on, among other things, the genotypes of mother and foetus and the stage of gestation at which the drug was given. The period of exposure of the embryo to the effects of the drug could be precisely timed by injecting nicotinamide two hours after the 6AN, in a quantity sufficient to prevent the teratogenic effects of the analogue when given concurrently (Pinsky and Fraser, I960) . When this treatment was applied to A/Jax mice on day iol of gestation, a large proportion of the embryos were resorbed. Most of the survivors had cleft lip, but it was not clear whether these defects had been induced by the treatment, or whether the embryos that were destined to have 'spontaneous' cleft lip had survived the treatment that killed their normal litter-mates. 
Results
The (3) and (4) show that the resorption frequencies following a standard treatment on day 2 or iIi are much lower (40 % and 39 %, respectively) than the day IoB value. There is no significant indication of a preferential survival of cleft lip embryos, but at this level of resorption the excess due to a sparing effect would be small anyway. Column (5) shows that, following a double dose of 6AN (intraperitoneally) on day iii, the excess of cleft lip embryos at term does not occur, even though the resorption frequency is high, so that the postulated differential resistance of cleft lip embryos seen at day io-is no longer present at day II 12.
The subsequent columns represent various treatments on day I o . It can be seen that whatever the resorption frequency, the number of cleft lip embryos is about that which is expected if all the cleft lip embryos that would have occurred without treatment had survived (bottom row of Table) . Thus in a series in which the dose of nicotinamide was doubled, to see if a single dose was counteracting the analogue (Column (6)), there were 54 implantations, of which 800% had resorbed. One would have expected 5 cleft lip embryos without treatment (IO % of 54) and in fact 5 were observed. Column (7) shows the results of a series in which the doses of 6AN and nicotinamide were reduced by one-quarter and given intraperitoneally to see if this route of administration would reduce interlitter variation. Again there is an excess of cleft lip embryos among the survivors. Column (8) shows that when the 6AN dose is reduced to half the resorption frequency falls, and the excess of cleft lip embryos among viable young disappears. Since the teratogenic dose range is generally somewhat lower than the embryo-lethal dose (Murphy, 
